Article
Radiopharmaceutical therapy of patients with metastasized melanoma with the melanin-binding benzamide 131I-BA52.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine - 1 Jan 2014
Mier Walter, Kratochwil Clemens, Hassel Jessica C, Giesel Frederik L, Beijer Barbro, Babich John W, Friebe Matthias, Eisenhut Michael, Enk Alexander, Haberkorn Uwe
Abstract excerpt
UNLABELLED: The performance of cytotoxic drugs is defined by their selectivity of uptake and action in tumor tissue. Recent clinical responses achieved by treating metastatic malignant melanoma with therapeutic modalities based on gene expression profiling showed that malignant melanoma is amenable to systemic treatment. However, these responses are not persistent, and complementary targeted treatment strategies...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.